Striving to write a new chapter in drug supervision in the new era. The National Drug Supervision and Administration Work Conference was held in Beijing


Release time:

2019-01-14

From January 10 to 11, the National Drug Supervision and Administration Conference was held in Beijing. The meeting was guided by Xi Jinping Thought on Socialism with Chinese Characteristics for a New Era, conscientiously implemented the spirit of the 19th National Congress of the Party and the Second and Third Plenary Sessions of the 19th Central Committee, implemented the deployment of the Central Economic Work Conference, summarized the work in 2018, and deployed the tasks for 2019. At the meeting, State Councilor Wang Yong's important instructions on drug supervision were conveyed. Zhang Mao, secretary of the party group and director of the State Administration for Market Regulation, attended the meeting and put forward requirements for further strengthening drug supervision. Liu Shi, member of the party group of the State Administration for Market Regulation and head of the discipline inspection and supervision team of the Central Commission for Discipline Inspection and the State Supervision Commission in the General Administration, attended the meeting. Li Li, member of the Party group of the State Administration of market supervision and administration, Secretary of the Party group and deputy director of the State Drug Administration, and Jiao Hong, director of the State Drug Administration, attended the meeting and delivered speeches. Xu Jinghe, Chen Shifei, and Yan Jiangying, members of the leading party group and deputy directors of the State Drug Administration, attended the meeting.

Participants agreed that the important instructions of State Councilor Wang Yong fully affirmed the achievements of drug supervision work, was a great encouragement to the cadres and employees of the national drug supervision system, and had important guiding significance for the drug supervision work in the new era. The whole system should conscientiously study and profoundly understand, implement the instructions of State Councilor Wang Yong, earnestly ensure the safety and effectiveness of drug use by the people, and strive to create a new situation in drug supervision in a new era.

In his speech, Zhang Mao fully affirmed the achievements made in drug supervision in 2018. He pointed out that in the past year, the national drug regulatory system has thoroughly studied and implemented Xi Jinping's thoughts on socialism with Chinese characteristics in the new era, the spirit of the 19th National Congress of the Communist Party of China and the Second and Third Plenary Sessions of the 19th Central Committee, earnestly implemented the decisions and deployments of the Party Central Committee and the State Council, and deepened reform and innovation., Strengthen daily supervision, smooth and orderly institutional reforms, proper response to emergencies such as problematic vaccines, continuous improvement of drug supervision, steady improvement, and steady improvement of the party building, remarkable achievements have been made in all aspects of work. He emphasized that drug safety is related to the health and well-being of the people, social stability, and the overall situation of economic development. The mission of the drug supervision system is glorious and arduous. Under the strong leadership of the CPC Central Committee with Comrade Xi Jinping at the core, we should constantly improve our political position, scientifically and accurately judge the requirements of the work situation, and take the initiative to put drug supervision work in the overall economic and social situation and in the overall situation of market supervision. we should improve and improve the regulatory system and mechanism, and implement the drug supervision responsibilities of local market supervision departments at all levels, especially at the city and county levels. Efforts should be made to implement the "four strictest", to prevent security risks, to form a joint force of supervision, to speed up the examination and approval, to build systems and mechanisms, to strengthen party building, to better implement the arrangements of the central authorities, to meet the expectations of the masses, to meet the needs of development, and to meet the challenges of the situation, with a stronger responsibility and a more solid work style, we will make the drug supervision work more refined, more detailed, more specialized, better and stronger, and make every effort to ensure the safe and effective use of drugs by the people.

The meeting pointed out that 2019 is the 70th anniversary of the founding of New China, the key year for building a moderately prosperous society in an all-round way, and the start of the comprehensive work of the drug supervision system after the institutional reform. The national drug regulatory system should be guided by Xi Jinping Thought on Socialism with Chinese Characteristics for a New Era, thoroughly implement the spirit of the 19th National Congress of the Communist Party of China and the Second and Third Plenary Sessions of the 19th Central Committee, and follow the deployment of the Central Economic Work Conference. "Requirements, adhere to the general tone of the work of seeking progress while maintaining stability, adhere to the new development concept, focus on strengthening the management of the entire life cycle of drugs, and promote the scientific development of supervision, we should pay attention to reform, ensure safety, improve quality and strengthen the foundation, constantly improve the regulatory system and mechanism, innovate the supervision methods and methods, strengthen risk management, deepen the implementation of responsibilities, improve the scientific, legal, international and modern level of drug supervision, effectively ensure the safety and effectiveness of drug use by the people, and strive to write a new chapter in drug supervision in the new era.

Li Li pointed out that it is necessary to deeply understand that ensuring drug safety is a serious political issue, a major economic issue, a basic livelihood issue, and a rigorous technical issue. From the perspective of maintaining the authority of the Party Central Committee with Comrade Xi Jinping at the core and consolidating the foundation of the party's governance To understand drug safety issues, we must be responsible, responsible, and responsible on the front of drug supervision. At present, China's drug supervision work is in the construction period of the new drug supervision system and mechanism, the resolution period of historical problems, the promotion period of high-quality drug development, and the remodeling period of the morale and image of the drug supervision system. The cadres and workers of the drug supervision system should further strengthen their confidence and make concerted efforts to promote the continuous progress of the cause of drug supervision.

Li Li emphasized that to do a good job in drug supervision this year, we must adhere to a direction and put the "most rigorous standards, the most stringent supervision, the most severe punishment, and the most serious accountability" proposed by General Secretary Xi Jinping throughout drug supervision. process. It is necessary to strengthen the two goals, strengthen the investigation and rectification of hidden risks, strengthen the supervision of high-risk products such as vaccines, implement the drug safety responsibilities of all parties, and firmly hold the bottom line of drug safety; deepen the reform of the review and approval system, optimize government services, support research and development innovation, and pursue high-quality drug development. It is necessary to consolidate the three supports, improve the laws and regulations system, establish and improve the drug supervision system, and strengthen the construction of supervision and guarantee capacity. It is necessary to uphold and comprehensively strengthen the party's leadership over drug supervision and control work, and promote the comprehensive and in-depth development of strict party management.

Jiao Hong deployed six key tasks in 2019: First, improve the regulatory and standard system and implement the "four most stringent" requirements. Actively promote the revision and implementation of laws and regulations, and accelerate the construction of the standard system. The second is to deepen the reform of the review and approval system and promote the high-quality development of the pharmaceutical industry. We will speed up the listing of new drugs, make every effort to promote the consistency evaluation of the quality and efficacy of generic drugs, further promote the reform of the examination and approval system for medical devices, and improve the registration and filing management of cosmetics. The third is to promote the improvement of the vaccine regulatory system and firmly hold the bottom line of safety. Strictly implement the power of vaccine supervision, strengthen supervision and inspection, increase the inspection and inspection of vaccine batch issuance, and implement case listing supervision. Fourth, adhere to the concept of risk management, strictly prevent and control risks. Strengthen the supervision and random inspection of high-risk key products, and crack down on illegal activities. The fifth is to promote the scientific research of supervision and improve the level of supervision modernization. Sixth, we will vigorously promote smart supervision and continue to innovate regulatory methods.

Jiao Hong put forward three requirements: First, enrich the supervision force, implement the supervision responsibility, compact the main responsibility of the enterprise, and strengthen the responsibility of territorial management. The second is to strengthen capacity building, consolidate the regulatory foundation, improve the quality management system of regulatory departments, establish and improve drug emergency management mechanisms, and promote the improvement of regulatory business capabilities. The third is to enhance the sense of service, enhance the effectiveness of supervision, practice the sense of service with action, and establish a new image of drug administration with clean supervision.

Representatives of drug administration departments of all provinces (autonomous regions and municipalities) and Xinjiang production and Construction Corps, departments, bureaus and units directly under the State Drug Administration attended the meeting. Representatives of relevant ministries and commissions were invited to attend the meeting.